As per MRFR analysis, the India Plasma Fractionation Market Size was estimated at 1.14 (USD Billion) in 2024The India Plasma Fractionation Market Industry is expected to grow from 1.18(USD Billion) in 2025 to 2.75 (USD Billion) by 2035. The India Plasma Fractionation Market CAGR (growth rate) is expected to be around 7.97% during the forecast period (2025 - 2035).
Key India Plasma Fractionation Market Trends Highlighted
The India Plasma Fractionation Market is experiencing notable trends driven by increasing healthcare needs and advancements in medical science. The rising incidence of chronic diseases, such as hemophilia and immunodeficiency disorders, is spurring demand for plasma-derived therapies. Furthermore, supportive government policies aimed at promoting the plasma industry are encouraging infrastructure development and investments in research and development. The Indian government has recognized the importance of blood and plasma donation, implementing initiatives to enhance collections and ensure a stable supply of raw materials for fractionation.
Recent trends highlight a growing focus on the expansion of domestic manufacturing capabilities, which is essential for reducing reliance on imports and ensuring quality standards in plasma products.Efforts to establish state-of-the-art plasma fractionation facilities are on the rise, aiming to enhance capacity and improve the availability of life-saving products. Additionally, India is increasingly seeking collaboration with global players and research institutions to harness innovative technologies in plasma processing, pointing towards a significant shift towards modernization in the industry.
Opportunities in the India Plasma Fractionation Market are abundant, particularly in enhancing public awareness around plasma donation and building trust in plasma-derived therapies. The rise of e-health platforms also offers a modern approach to managing patient needs and streamlining the donation process.There is a noticeable trend towards integrating technology in donor management and product distribution, making it easier for healthcare providers to access needed therapies swiftly. Overall, the combination of rising healthcare needs, supportive government policies, and advancements in technology positions the India Plasma Fractionation Market for sustained growth and innovation in the years ahead.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
India Plasma Fractionation Market Drivers
Increase in Demand for Immunoglobulins
The demand for immunoglobulins in the India Plasma Fractionation Market Industry is significantly rising due to their effectiveness in treating various immunodeficiency disorders, autoimmune diseases, and infections. According to the Indian Council of Medical Research, approximately 2.5 million individuals in India suffer from primary immune deficiencies, leading to a growing need for immunoglobulin therapy. Furthermore, the market for immunoglobulins is anticipated to witness a compound annual growth rate of over 10% from 2025 to 2035.The Indian plasma and fractionation companies such as Indian Immunologicals and Kedarnath Ghosh are already ramping up their production capacities to meet this increasing demand, thereby confirming a robust growth pathway for the plasma fractionation market in India.
Rising Awareness and Acceptance of Plasma-derived Therapies
In India, there is a growing awareness of the benefits of plasma-derived therapies among both healthcare providers and patients. Educational initiatives by the National Blood Transfusion Council have played a crucial role in making the population more aware of the therapeutic potential of plasma products. A survey conducted by the Ministry of Health and Family Welfare indicated that around 60% of healthcare professionals now advocate the usage of plasma therapies in treatment regimens, resulting in increased patient acceptance.
More health systems are expected to integrate these therapies, which will further advance understanding and acceptance, thus increasing the India Plasma Fractionation Market Industry.
Government Support and Regulations Favoring Plasma Collection
The Indian Government, through its 'National Blood Policy,,' is emphasizing the need for a robust blood and plasma collection system to ensure the availability of life-saving therapies. Recent amendments by the Drugs and Cosmetics Act allow for easier licensing and regulation of plasma fractionation centers, which is promoting established organizations such as the Serum Institute of India and Biocon to expand their operations in the plasma fractionation space.Moreover, the government aims for a 30% increase in plasma collection rates by 2025, which can significantly enhance the supply the plasma fractionation market. This supportive regulatory environment promises great potential for growth in the India Plasma Fractionation Market Industry.
India Plasma Fractionation Market Segment Insights
Plasma Fractionation Market Product Type Insights
The India Plasma Fractionation Market has seen a notable expansion, particularly in its Product Type segmentation, which includes various integral components such as Immunoglobulin, Albumin, Coagulation Factors, and Protease Inhibitors. Immunoglobulin plays a crucial role in the treatment of immune deficiencies and autoimmune diseases, leading to its robust demand within healthcare facilities across India. The increasing prevalence of such health issues has made Immunoglobulin a dominant factor in the Plasma Fractionation Market, capturing a significant share.Albumin stands out as another vital fraction, widely utilized in clinical settings, particularly for fluid replacement in patients with liver diseases or undergoing surgeries.
Its applications in maintaining oncotic pressure further enhance Albumin's standing in the market. Coagulation Factors, essential for patients with bleeding disorders such as hemophilia, highlight the growing importance of tailored therapies in the Plasma Fractionation Market. As awareness of such conditions increases, the demand for these factors is expected to rise accordingly.Protease Inhibitors, while less observed than the aforementioned types, offer valuable therapeutic avenues for diseases requiring intervention in protein degradation processes. The diverse utility of these subtypes demonstrates their interconnectedness to patient care and the overall advancement in medical practices in India.
Factors such as rising healthcare expenditure, technological advancements in fractionation techniques, and an increasing focus on plasma-derived products for better patient outcomes are expected to drive the growth of the India Plasma Fractionation Market.The trend toward personalized medicine and increased government initiatives supporting blood donation and plasma collection further enhance the market's landscape, fostering opportunities for innovation and development in plasma fractions. Overall, the continued momentum in the Product Type segmentation underscores the critical role these fractions play in addressing various health challenges in India, charting a progressive trajectory for the market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Plasma Fractionation Market Application Insights
The India Plasma Fractionation Market, particularly the Application segment, showcases significant diversity with its focus on Neurology, Hematology, General Medicine, and Immunology. Neurology is crucial, as the growing prevalence of neurological disorders necessitates the increasing demand for plasma-derived therapies. Hematology stands out due to the rising incidence of blood-related diseases, which drives innovation and product availability in this area. General Medicine further complements this market by incorporating plasma products for various therapeutic applications, playing a vital role in patient care.Immunology is gaining momentum, largely influenced by the increasing awareness of immunological disorders and the evolving landscape of treatment modalities.
As healthcare infrastructure in India continues to advance, these applications are expected to thrive, driven by government initiatives supporting Research and Development in this domain and the rising healthcare expenditures. Overall, the diverse applications of plasma fractionation demonstrate its critical importance in addressing substantial health challenges faced by the Indian population.
Plasma Fractionation Market End User Insights
The End User segment of the India Plasma Fractionation Market is a critical aspect, encompassing various key areas such as Hospitals, Ambulatory Surgical Centers, Blood Banks, and Pharmaceutical Companies. Hospitals play a vital role due to their need for plasma-derived therapies for treating various conditions, including immunodeficiencies and bleeding disorders. Ambulatory Surgical Centers are increasingly significant as they cater to patients requiring outpatient procedures, leveraging efficient plasma handling. Blood Banks are essential for collection and safe distribution of plasma products, ensuring availability for transfusions and other medical uses; thus, they hold a crucial position in maintaining a steady supply chain.
Pharmaceutical Companies are also major player, engaging in Research and Development of innovative therapies derived from plasma, contributing to improved patient outcomes. As the Indian healthcare system evolves, each of these segments continues to adapt and grow, influenced by factors such as increased disease prevalence, growing awareness of plasma therapies, and advances in technology that enable better plasma processing and product development. This dynamic landscape presents numerous opportunities for collaboration and innovation, further shaping the future of the India Plasma Fractionation Market.
Plasma Fractionation Market Technology Insights
The Technology segment of the India Plasma Fractionation Market encompasses various techniques that play a vital role in the separation and purification of blood plasma components. Centrifugation is pivotal, as it utilizes centrifugal force to separate plasma proteins based on their densities, streamlining the extraction process. Chromatography is significant for its precision in isolating specific proteins, widely used in therapeutic and diagnostic applications. Precipitation methods are noted for their cost-effectiveness and ease of implementation, making them an attractive option for laboratories seeking efficient solutions.Filtration technology is increasingly critical in ensuring the purity and safety of plasma products, aligning with stringent regulatory standards in India’s healthcare sector.
Collectively, these technologies not only enhance the efficiency of plasma fractionation but also support the growing demand for immunoglobulins and clotting factors in the country. The evolution and integration of these sophisticated techniques further underscore the strong foundation of the India Plasma Fractionation Market, driven by advancements in Research and Development and increasing healthcare needs.Overall, the Technology segment remains essential in addressing both current challenges and future opportunities in plasma-derived therapies within India.
India Plasma Fractionation Market Key Players and Competitive Insights
The India Plasma Fractionation Market is a rapidly evolving sector characterized by a demand for high-quality plasma-derived products that are essential for treating various medical conditions. The competitive landscape of this market is marked by both established and emerging players who compete on various fronts, including product quality, innovation, regulatory compliance, and pricing strategies. Factors such as increasing awareness of blood disorders, rising healthcare expenditures, and growing acceptance of immunoglobulin therapies are influencing the dynamic competition. Additionally, advancements in technology and techniques related to plasma collection and processing are creating opportunities for companies to enhance their operational efficiencies and expand their product offerings to address the growing demand in the country.Octapharma, a notable presence in the India Plasma Fractionation Market, has established itself with a strong emphasis on quality and innovation.
The company benefits from a robust portfolio of immunoglobulin and albumin products, which are pivotal in treating various immune deficiencies and coagulation disorders. Octapharma differentiates itself through its commitment to research and development, ensuring alignment with the latest therapeutic standards and trends in the healthcare industry. This dedication is reflected in its ability to adapt to the unique needs of the Indian market, fostering strong relationships with healthcare providers and hospitals.
Furthermore, Octapharma's strategic collaborations within the region strengthen its distribution network, ensuring that its products are accessible to a wider patient population while maintaining high standards of supply chain management and regulatory compliance.Indian Immunologicals is recognized in the India Plasma Fractionation Market for its extensive range of products that cater to both human and animal health needs.
The company specializes in producing immunoglobulin preparations and other plasma-derived products, making significant contributions to the healthcare sector in India. Indian Immunological focuses on enhancing its market presence through strategic investments and partnerships, which allow for the expansion of its production facilities and research capabilities. Its strengths lie in its ability to provide affordable and effective healthcare solutions while maintaining stringent quality controls and adhering to regulatory frameworks.
The company actively engages in collaborations and mergers that provide leverage for operational scalability and technological advancements in product offerings. With an agile approach to market demands and a strong commitment to social responsibility, Indian Immunologicals continues to solidify its reputation as a key player in the plasma fractionation market, focused on addressing the health challenges within the Indian population.
Key Companies in the India Plasma Fractionation Market Include
India Plasma Fractionation Market Industry Developments
The India Plasma Fractionation Market has experienced significant developments recently, particularly as the demand for plasma-derived therapeutics expands. Companies like Serum Institute of India and Reliance Life Sciences have made strides in increasing their production capacities to meet rising healthcare requirements. In August 2023, Indian Immunologicals announced plans to enhance its plasma collection capacity and invest in new fractionation technologies.
Additionally, the market has seen an increase in collaborations aimed at research and development, with Biocon partnering with Cangene Corporation to innovate in biopharmaceuticals.In terms of mergers and acquisitions, Karnataka Antibiotics and Pharmaceuticals and Haffkine BioPharmaceutical Corporation were reported to be exploring synergies through shared technologies in January 2023. The market has demonstrated robust growth, with a valuation boost from ongoing investments and expansion efforts, fostering a competitive landscape.
Over the last two years, the market has been buoyed by new regulations promoting domestic production and self-sufficiency in vital plasma products, aligning with India's health initiatives. This ongoing evolution in the sector signals a pivotal time for growth opportunities among key players.
India Plasma Fractionation Market Segmentation Insights
Plasma Fractionation Market Product Type Outlook
Plasma Fractionation Market Application Outlook
Plasma Fractionation Market End User Outlook
Plasma Fractionation Market Technology Outlook
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 1.14 (USD Billion) |
| MARKET SIZE 2024 | 1.18 (USD Billion) |
| MARKET SIZE 2035 | 2.75 (USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.97% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Octapharma, Indian Immunologicals, CPV Manufacturing, Reliance Life Sciences, Biocon, Cangene Corporation, Karnataka Antibiotics and Pharmaceuticals, Shantha Biotechnics, Swarna Biotech, Haffkine BioPharmaceutical Corporation, Serum Institute of India, Bharat Biotech, Blood Bank of India, Transfusion and Transplantation Technologies |
| SEGMENTS COVERED | Product Type, Application, End User, Technology |
| KEY MARKET OPPORTUNITIES | Increasing healthcare investments, Rising prevalence of hemophilia, Expansion of biopharmaceutical manufacturing, Growing need for immunoglobulin therapies, Development of advanced fractionation technologies |
| KEY MARKET DYNAMICS | growing prevalence of hemophilia, increasing demand for immunoglobulin therapies, advancements in fractionation technologies, supportive government regulations, rising investment in plasma collection centers |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Plasma Fractionation Market is expected to be valued at 2.75 USD Billion by 2035.
In 2024, the India Plasma Fractionation Market was valued at 1.18 USD Billion.
The expected CAGR for the India Plasma Fractionation Market from 2025 to 2035 is 7.97%.
The Immunoglobulin segment is projected to hold the largest market share, valued at 1.26 USD Billion by 2035.
Key players in the market include Octapharma, Indian Immunologicals, Reliance Life Sciences, and Serum Institute of India.
The Albumin segment is expected to be valued at 0.93 USD Billion by 2035.
Potential challenges include regulatory hurdles and competition from alternative therapies in plasma products.
Regional demand significantly influences the market growth as various regions exhibit differing levels of healthcare infrastructure and plasma collection capabilities.
The Coagulation Factors segment is projected to reach a value of 0.43 USD Billion by 2035.
Emerging trends include advancements in plasma processing technologies and an increasing focus on rare disease treatments driving demand.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
